Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001461993-17-000005
Filing Date
2017-11-20
Accepted
2017-11-20 17:13:56
Documents
1
Effectiveness Date
2017-11-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14543
  Complete submission text file 0001461993-17-000005.txt   15892
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-299206 | Film No.: 171214579
SIC: 2834 Pharmaceutical Preparations